Names and Identifiers

• • Ziprasidone
  • -(2-(4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one
  • 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one
  • ZIPRASIDON
  • Ziprasidone solution
  • CP 88059
  • CP-88059
  • Geodon
  • UNII-6UKA5VEJ6X
  • Zeldox
  • ziprasidona
  • Ziprasidone [INN:BAN]
  • ziprasidonum
  • ziprazidone
  • 5-(2-(4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one
  • ZIPRASIDONE-D8
  • Ziprasidone HBr
  • CP-88059：CP-88059-1
  • Hydrochloric acid(base)
  • ZIPRASIDONE: ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE
  • 5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one
  • Ziprasidone hydrochloride
  • Ziprasidone mesylate trihydrate
  • 6UKA5VEJ6X
  • C21H21ClN4OS
  • DSSTox_CID_3753
  • DSSTox_RID_77186
  • DSSTox_GSID_23753
  • 2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-
  • 5-(2-(4-(benzo[d]isothiazol-3-yl)
  • N05AE04
  • NCGC00263539-03
  • DTXSID4023753
  • AKOS015900383
  • AB00639925_06
  • Q205517
  • AB00639925_05
  • ARD10222
  • 5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one (Ziprasidone)
  • MLS000759435
  • BZ164575
  • 5-(2-(4-(1,2-benzothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one
  • 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one
  • SMR000466328
  • Z0034
  • Zipradon (TN)
  • Ziprasidone- Bio-X
  • 5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-2,3-dihydro-1H-indol-2-one
  • GTPL59
  • EN300-7415908
  • 5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one
  • HY-14542
  • NCGC00263539-01
  • L000659
  • 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indole-2-one
  • VU0286234-2
  • HMS3742M19
  • BRD-K29582115-066-01-2
  • ZIPRASIDONE [MART.]
  • 5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
  • D92803
  • CS-1071
  • HSDB 7745
  • AB00639925-04
  • D08687
  • C07568
  • ZIPRASIDONE [INN]
  • Tox21_113525
  • AC-23360
  • NCGC00263539-05
  • CHEMBL708
  • 6-chloro-5-
  • Ziprasidone (INN)
  • NS00004565
  • Ziprasidone, 1mg/ml in 1,2-Dimethoxyethane
  • ZIPRASIDONE [WHO-DD]
  • 5-(2-(4-(1,2-benzisothiazol-3-yl)piperazinyl)ethyl)-6-chlorooxindole
  • 5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one(Norastemizole)
  • Tox21_112194
  • NCGC00263539-13
  • Tox21_112194_1
  • Ziprasidone NX
  • BIDD:GT0042
  • Ziprasidone free base
  • ZIPRASIDONE [VANDF]
  • Zipradon
  • ZIPRASIDONE (MART.)
  • ZIPRASIDONE [HSDB]
  • SCHEMBL28028
  • DB00246
  • 5-(2-(4-(3-benzisothiazolyl)piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one
  • NCGC00186050-01
  • SDCCGSBI-0633778.P001
  • CAS-146939-27-7
  • BDBM50048803
  • 5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
  • BRD-K29582115-003-03-1
  • ZIPRASIDONE [MI]
  • 146939-27-7
  • 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one;hydrate;hydrochloride
  • 2H-Indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-
  • CP-88059-27
  • BVB74558
  • CHEBI:10119
  • 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one
  • DTXCID403753
  • AB00639925-02
  • +expand
• • MDL： MFCD00866661
  • Inchi： 1S/C21H21ClN4OS/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21/h1-4,11,13H,5-10,12H2,(H,23,27)
  • InChI Key： MVWVFYHBGMAFLY-UHFFFAOYSA-N
  • SMILES： ClC1C([H])=C2C(C([H])([H])C(N2[H])=O)=C([H])C=1C([H])([H])C([H])([H])N1C([H])([H])C([H])([H])N(C2C3=C([H])C([H])=C([H])C([H])=C3SN=2)C([H])([H])C1([H])[H]

Computed Properties

Experimental Properties